David Lawrence
2010
In 2010, David Lawrence earned a total compensation of $1.4M as Chief Financial Officer at Acorda Therapeutics, a 56% increase compared to previous year.
Compensation breakdown
| Bonus | $114,038 |
|---|---|
| Option Awards | $558,146 |
| Salary | $270,883 |
| Stock Awards | $470,250 |
| Other | $7,350 |
| Total | $1,420,667 |
Lawrence received $558.1K in option awards, accounting for 39% of the total pay in 2010.
Lawrence also received $114K in bonus, $270.9K in salary, $470.3K in stock awards and $7.4K in other compensation.
Rankings
In 2010, David Lawrence's compensation ranked 4,129th out of 10,439 executives tracked by ExecPay. In other words, Lawrence earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,129 out of 10,439 | 60th |
Division Manufacturing | 1,459 out of 3,838 | 62nd |
Major group Chemicals And Allied Products | 286 out of 921 | 69th |
Industry group Drugs | 157 out of 680 | 77th |
Industry Biological Products, Except Diagnostic Substances | 27 out of 142 | 81st |
Source: SEC filing on April 19, 2013.
Lawrence's colleagues
We found four more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2010.